Skip to content

Absolute Pro 1012538-80Recalls & reported problems

Abbott Vascular Inc. · Absolute Pro Vascular Self-Expanding Stent System 10.0 mm x 80 mm x 135 cm / Over-The-Wire · Class 3 · Implant

All models of Absolute Pro (51)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648176302), received between Aug 28, 2018 and Nov 19, 2025 — classified as 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation Failure1
  • Break1
  • Defective Device1
  • Device Contaminated During Manufacture or Shipping1
  • Difficult or Delayed Activation1
  • Material Deformation1
  • Mechanical Jam1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Consequences Or Impact To Patient1
  • No Patient Involvement1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 19, 2025Break; Activation Failure; Break; Activation Failure

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A HEAVILY CALCIFIED, MILDLY TORTUOUS ILIAC ARTERY THAT IS 85% STENOSED. THE ARTERY WAS BALLOONED WITH AN UNSPECIFIED BALLOON AND A 10X80MM ABSOLUTE PRO SELF-EXPANDING STENT WAS ATTEMPTED TO BE DEPLOYED; HOWEVER, THE OUTER SHEATH OF THE STENT FRACTURED AND THE STENT PARTIALLY DEPLOYED. THE DEVICE WAS REMOVED AND ANOTHER STENT WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23598089 ↗
  • InjuryNov 25, 2023Difficult or Delayed Activation; Material Deformation; Mechanical Jam; Difficult or Delayed Activation; Material Deformation; Mechanical Jam

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT THE EXTERNAL ILIAC VEIN WITH NO CALCIFICATION AND NO TORTUOSITY. DURING THE PROCEDURE, THE THUMBWHEEL OF THE 10X80 MM ABSOLUTE PRO SELF EXPANDING STENT SYSTEM (SESS) WOULD NOT ROLL BACK; HOWEVER, THE STENT WAS DEPLOYED BUT IT WAS MANGLED. THE STENT REMAINS FULLY INSIDE THE TARGET LESION. THERE WAS ADDITIONAL BALLOON DILATATION TO FULLY EXPAND THE STENT. THERE WERE NO ADVERSE PATIENT SEQUELA AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18207622 ↗
  • MalfunctionMay 19, 2020Defective Device; Defective Device

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A RIGHT ILIAC ARTERY. A 10X80MM ABSOLUTE PRO STENT WAS DEPLOYED WITHOUT ISSUE AND IT WAS THEN NOTED THAT THE STENT HAD SHORTENED. A 10X100MM ABSOLUTE PRO STENT WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10069668 ↗
  • MalfunctionAug 28, 2018Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED THAT DURING INCOMING INSPECTION AT THE DISTRIBUTION CENTER, BLACK FOREIGN MATERIAL WAS NOTED IN THE SEALED PACKAGING OF THE ABSOLUTE PRO VASCULAR STENT SYSTEM. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Patient Involvement

    MAUDE report 7823658 ↗

Other STENT, ILIAC devices

All STENT, ILIAC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page